Alentis Therapeutics and CSL are joining forces to develop and commercialize lixudebart, an infusion treatment candidate for people with ANCA-associated vasculitis (AAV) who also have rapidly progressive glomerulonephritis (RPGN), a severe form of kidney damage. The partnership joins Alentis‘ expertise as lixudebart’s original developer with CSL‘s…
Discussion
If you’re in the U.S., here is a small experiment you can run right now: Google the price of any prescription drug. Whatever number comes back is the list price, and it’s worth knowing that almost no one actually pays that amount. Think of it like the sticker price on…
Discussion
Orbital MRI scans, which assess the tissues surrounding the eyes, may help differentiate granulomatosis with polyangiitis (GPA) from other conditions affecting the eye socket, a new study demonstrates. “From a clinical perspective, [the identified] imaging features can help differentiate GPA from its mimics, guide timely biopsy decisions, and support…
Becoming educated and informed about ANCA vasculitis is a good first step. Here you’ll find general information such as the diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your ANCA vasculitis journey.
There is no cure for ANCA vasculitis yet, but here you can find more information about current approved treatments, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
